Detailed Information for C00975

Basic information about inhibitors

IPAD-DB ID C00975
Name Naringin
Category Natural compounds
2D Structure
3D Structure
Molecular Formula C 2 7 H 3 2 O 1 4
Molecular Weight 580.5g/mol
IUPAC Name (2S)-7-[(2S, 3R, 4S, 5S, 6R)-4, 5-dihydroxy-6-(hydroxymethyl)-3-[(2S, 3R, 4R, 5R, 6S)-3, 4, 5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-2, 3-dihydrochromen-4-one
InChI InChI=1S/C27H32O14/c1-10-20(32)22(34)24(36)26(37-10)41-25-23(35)21(33)18(9-28)40-27(25)38-13-6-14(30)19-15(31)8-16(39-17(19)7-13)11-2-4-12(29)5-3-11/h2-7, 10, 16, 18, 20-30, 32-36H, 8-9H2, 1H3/t10-, 16-, 18+, 20-, 21+, 22+, 23-, 24+, 25+, 26-, 27+/m0/s1
InChIKey DFPMSGMNTNDNHN-ZPHOTFPESA-N
Canonical SMILES CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC=C(C=C5)O)O)CO)O)O)O)O)O
PubChem CID 442428
DrugBank Accession Number -
CAS Registry Number 10236-47-2

Biological activity data

Ki -
EC50 -
IC50 -
Inhibition -
Toxicity -
ROS(reactive oxygen species) -
Metal Chelating -
BBB(blood-brain barrier) -
Target Protein Aβ42 pentamer
Effects -
Research Models Ensemble docking and molecular dynamics (MD) simulations
Main Source -
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME) 580.53
Hac(Computed by SwissADME) 41
Volume(Computed by ADMETlab 2.0) 537.374
Density(Computed by ADMETlab 2.0) 1.08
nRing(Computed by ADMETlab 2.0) 5
MaxRing(Computed by ADMETlab 2.0) 10
nHet(Computed by ADMETlab 2.0) 14
fChar(Computed by ADMETlab 2.0) 0
nRig(Computed by ADMETlab 2.0) 30
Flexibility(Computed by ADMETlab 2.0) 0.2
Stero Centers(Computed by ADMETlab 2.0) 11
LogS(Computed by ADMETlab 2.0) -3.43
LogD(Computed by ADMETlab 2.0) 1.065

ADMET properties

logP(Computed by ADMETlab 2.0) -1.17
TPSA(Computed by SwissADME) 225.06 Ų
Hbond Acceptor(Computed by SwissADME) 14
Hbond Donor(Computed by SwissADME) 8
Rotatable Bonds(Computed by SwissADME) 6

Pharmacokinetics

GI Absorption(Computed by SwissADME) Low
BBB(blood-brain barrier) Permeant(Computed by SwissADME) No
P-gp Substrate(Computed by SwissADME) Yes
CYP1A2 Inhibitor(Computed by SwissADME) No
CYP2C19 Inhibitor(Computed by SwissADME) No
CYP2C9 Inhibitor(Computed by SwissADME) No
CYP2D6 Inhibitor(Computed by SwissADME) No
CYP3A4 Inhibitor(Computed by SwissADME) No
log Kp(Skin Permeation)(Computed by SwissADME) -10.15 cm/s

Druglikeness

Lipinski(Computed by SwissADME) No, 3 violations: MW>500, NorO>10, NHorOH>5
Ghose(Computed by SwissADME) No, 4 violations: MW>480, WLOGP<-0.4, MR>130, #atoms>70
Veber(Computed by SwissADME) No, 1 violation: TPSA>140
Egan(Computed by SwissADME) No, 1 violation: TPSA>131.6
Muegge(Computed by SwissADME) No, 3 violations: TPSA>150, H-acc>10, H-don>5
Bioavailability Score(Computed by SwissADME) 0.17